Actively Recruiting

Phase 2
Age: 18Years +
All Genders
NCT05796375

Replacing Invasive Cystoscopy With Urine Testing for Non-muscle Invasive Bladder Cancer Surveillance

Led by White River Junction Veterans Affairs Medical Center · Updated on 2026-05-04

240

Participants Needed

9

Research Sites

267 weeks

Total Duration

On this page

Sponsors

W

White River Junction Veterans Affairs Medical Center

Lead Sponsor

N

National Cancer Institute (NCI)

Collaborating Sponsor

AI-Summary

What this Trial Is About

The purpose of this research is to determine whether bladder cancer monitoring can be improved by replacing some cystoscopy procedures with urine testing. Specifically, this study examines whether there are any differences in urinary symptoms, discomfort, number of invasive procedures, anxiety, complications, cancer recurrence or cancer progression when some cystoscopy procedures are replaced with urine testing.

CONDITIONS

Official Title

Replacing Invasive Cystoscopy With Urine Testing for Non-muscle Invasive Bladder Cancer Surveillance

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Age 18 years or older
  • History of low grade intermediate-risk non-muscle invasive bladder cancer meeting any of the following: multifocal low grade non-invasive urothelial carcinoma of any size; solitary low grade non-invasive urothelial carcinoma larger than 3cm; or recurrent low grade non-invasive urothelial carcinoma
  • Willingness to comply with all study procedures and availability for the study duration
  • No evidence of recurrence at cystoscopy within 6 months after most recent tumor removal
  • Ability to consent in English or Spanish
Not Eligible

You will not qualify if you...

  • History of total bladder removal (cystectomy)
  • History of urinary diversion surgery (such as neo-bladder, colon pouch, or ileal conduit)
  • History of muscle-invasive bladder tumor
  • Pregnancy or breastfeeding
  • History of urothelial carcinoma in ureter or renal pelvis with recurrent upper tract disease, unless recurrence free after nephroureterectomy
  • Anatomical issues preventing cystoscopy, such as urethrectomy or urethral stricture
  • Inability to provide a urine sample for testing

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 9 locations

1

West Haven VA Medical Center

West Haven, Connecticut, United States, 06516

Actively Recruiting

2

Bay Pines VA Healthcare System

Bay Pines, Florida, United States, 33744

Actively Recruiting

3

James A. Haley Veterans' Hospital

Tampa, Florida, United States, 33612

Actively Recruiting

4

VA Boston Jamaica Plains Campus

West Roxbury, Massachusetts, United States, 02132

Actively Recruiting

5

VA St.Louis Healthcare System

St Louis, Missouri, United States, 63016

Actively Recruiting

6

University Hospitals Cleveland Medical Center

Cleveland, Ohio, United States, 44106

Actively Recruiting

7

Medical University of South Carolina

Charleston, South Carolina, United States, 29425

Active, Not Recruiting

8

UT Southwestern Medical Center

Dallas, Texas, United States, 75235

Actively Recruiting

9

White River Junction Veterans Healthcare System

White River Junction, Vermont, United States, 05009

Actively Recruiting

Loading map...

Research Team

P

Prabhavathi Loganathan, MS

CONTACT

L

Laura Jensen, MPH

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

HEALTH_SERVICES_RESEARCH

Number of Arms

3

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here